investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

A Randomized Trial of Tac/MTX/bortezomib vs Tac/MTXplacebo in Allogeneic HSCT

Joseph H Antin

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Ann Moorman

T Cell Immunity in Endemic Burkitt Lymphoma

Non-Hodgkin lymphoma

Pediatric oncology or childhood cancer

Jon C Aster

Oncogenic Notch Signaling

Leukaemia

Pathology Hematology and hematologic malignancies

Michael Clarke

Self-renewal of Normal and Leukemic Stem Cells

Hodgkin lymphoma Leukaemia Non-Hodgkin lymphoma

Derek B. Sant'Angelo

Control of cytokine production by human NK cells

Leukaemia

Catherine Ju-Ying Wu

Defining the impact of clonal evolution on chronic lymphocytic leukemia

Leukaemia

Nya D Nelson

Elucidating the role of TIN2L at the telomere and in dyskeratosis congenita

Leukaemia

Pathology

Kristen Elizabeth Norman Scott

c-MYC dependent regulation of de novo lipogenesis in B-cell lymphomagenesis

Non-Hodgkin lymphoma Hodgkin lymphoma

Julie Aurore Losman

The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia

Leukaemia

Andrew A Lane

Targeting Chromatin Modifications in Leukemia with Trisomy 21

Leukaemia